In an age when expensive biologic agents get all of the attention, could adding something as simple and inexpensive as fish oil to disease-modifying anti-rheumatic drugs (DMARDs) in patients with rheumatoid arthritis make a difference? Could it delay the progression to more intensive, expensive, and risky therapies?
A number of studies using fish oil have shown it can reduce the number of tender joints and duration of morning stiffness in patients with rheumatoid arthritis (RA).... Read More
To some, “home-based primary care” (HBPC) may evoke images of frail shut ins — unable to leave their homes due to physical, mental, or cognitive impairments. Others imagine a nostalgic past when physicians made house calls to acutely ill patients. The aging of America is no secret.1 With aging, comes an increased burden of disease and pharmacotherapy.2 Those with multiple chronic conditions are high utilizers of health care resources.3-5 A small number... Read More
Achieving provider status has been the latest buzz for many pharmacy organizations over the past year. Provider status will likely lead to increased access to pharmacists' services in the ambulatory care setting and inclusion of medication therapy management by pharmacists as an essential benefit in emerging healthcare delivery models. Arguably the most important goal in achieving provider status is payment for pharmacists' patient care services under Medicare Part B. The key to... Read More